Industry Reports
CPhI series reporting successful first half to 2019
The CPhI global pharma event series – part of Informa Market’s Health & Nutrition business – continues to surge ahead in 2019 with its global editions securing increased visitor and exhibitor numbers. The events’ successes have...
Industry Reports
Ampersand Capital Partners to Acquire Vibalogics GmbH
Vibalogics GmbH, a contract development and manufacturing organization (CDMO) focused on complex live biological products, is being acquired by Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the healthcare sector. Ampersand’s...
Industry Reports
CPhI China opens with analysis pointing to a surge in growth in 2019
New analysis released ahead of CPhI & P-MEC China (#CPhIChina and #PMECChina) – co-organized by Informa Markets, CCCMHPIE, and Shanghai Sinoexpo Informa Markets – forecasts that China will continue to grow strongly through 2019/20, thanks in part to a...
Industry Reports
Zenith Technologies sees 400% China growth in latest Asia success
Zenith Technologies, a world leader in delivering manufacturing software solutions to the life sciences industry, has reported 400 per cent growth in its Chinese operations in the last 3 years. The company now has a presence...
Industry Reports
Wasdell Group strengthens offering with Honeywood acquisition
The Wasdell Group (Wasdell), a leading outsourcing partner for companies in the pharmaceutical industry, has announced its acquisition of Honeywood Limited, a specialist manufacturer and packager located in Northampton, UK. The acquisition will strengthen and expand...
Industry Reports
AI in life sciences still being held back by data issues and skills shortage, finds survey from The Pistoia Alliance
The Pistoia Alliance, a global non-profit that works to lower barriers to innovation in life sciences R&D, announced new survey results showing access to data (52 percent) and lack of skills (44 percent) are the biggest barriers to...
Industry Reports
Surge of Indian biosimilars market forecast in 2019
New data from CPhI shows that, despite ongoing reputational challenges, India’s biologics market is set for robust growth in 2019 driven by biosimilars production. The India specific findings from CPhI’s bio league tables predict strong ‘bio...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
